Clinical Trials Browser

Phase 2 × Efficacy and Safety × Temozolomide × Clear all

NCT03660761 2019-04-16

Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors

Phase 2 Completed

Efficacy and Safety